Description

The Peritonitis Index of Altona II (PIA II) was developed to evaluate patients with intra-abdominal infections. Discriminant analysis was used to rank variables and to assign a weighting value, according to their ability to separate patients into survivors and nonsurvivors. The index was developed at Allgemeines Krankenhaus Altona in Hamburg, Germany.


 

Risk factors:

(1) gender

(2) age

(3) duration of peritonitis

(4) congestive heart failure

(5) diabetes mellitus

(6) leukocyte (WBC) count

(7) serum creatinine

(8) diffuse peritonitis

(9) peritonitis due to mesenteric infarction

(10) intestinal strangulation

(11) site of perforation (peptic ulcer, appendix, colon)

Parameter

Finding

Weighting

gender

male

-0.61

 

female

0

age

> 60 years

-0.38

 

<= 60 years

0

duration of peritonitis

> 48 hours

-0.40

 

<= 48 hours

0

congestive heart failure

present

-0.47

 

absent

0

insulin dependent diabetes mellitus

present

-1.36

 

absent

0

leukocyte count

> 26,000 per µL

-2.47

 

5,000 – 26,000 per µL

0

 

< 5,000 per µL

-2.47

serum creatinine

> 4 mg/dL

-0.75

 

<= 4 mg/dL

0

diffuse peritonitis

present

-0.34

 

absent

0

peritonitis due to mesenteric infarction

present

-4.19

 

absent

0

intestinal strangulation

present

-2.74

 

absent

0

peptic ulcer perforation

present

0.49

 

absent

0

perforated appendicitis

present

0.62

 

absent

0

colonic perforation

present

0.77

 

absent

0

 

where:

• The original tables refer to creatine rather than creatinine.

 

PIA II index =

= SUM(weighting for all of the risk factors) + 2.02

 

Interpretation:

• minimum score: < -8.0

• maximum score: 3.9

• A high score is associated with a low mortality rate (high survival).

 

PIA II Index

Mortality in Postoperative Group

Mortality in Other Group

> 2

0

0

0 – 2

11.6%

5%

-2 to 0

55.5%

55.3%

< -2

76.9%

88.8%

from Kologlu et al (2001), Figure 2, page 148.

 

Performance:

• Wittman et al (1987) found that the score correctly classified 89% of patients in the test group and 81% of a control group.

• Ohmann et al found that the APACHE II score was superior in its discriminatory ability and reliability (although the graph of PIA II scores in Figure is opposite to the data above).

 


To read more or access our algorithms and calculators, please log in or register.